Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

SGRY stock hub

Surgery Partners, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SGRYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SGRY

In the news

Latest news · SGRY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E30.7

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE2.7

P25 -106.6P50 -46.9P75 -3.1

ROIC5.5

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SGRY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001638833
Company name	Surgery Partners, Inc.
Country	United States
Country code	US
Cusip	86881A100
Employees	16,000
Employees Change	1,000%
Employees Change Percent	6.67
Enterprise value	$5.7B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
IPO Date	2015-10-01
Isin	US86881A1007
Last refreshed	2026-05-10
Market cap	$1.9B
Market cap category	Small-Cap
Price	$14.44
Price currency	USD
Rev Per Employee	208,975x
Sector	Healthcare
Sic	8062
Symbol	SGRY
Website	https://www.surgerypartners.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.07%
EV Sales Forward	1.63x
EV/EBIT	12.08x
EV/EBITDA	8.78x
EV/FCF	27.54x
EV/Sales	1.71x
FCF yield	11.12%
Forward P/E	30.71x
P/B ratio	1.11x
P/S ratio	0.56x
PEG ratio	2.25x
PS Forward	0.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.18%
EBITDA Margin	19.51%
FCF margin	6.22%
Gross margin	22.83%
Gross Profit	$763.3M
Gross Profit Growth	1.48%
Gross Profit Growth Q	-1.05%
Gross Profit Growth3 Y	9.33%
Gross Profit Growth5 Y	13.32%
Net Income	$-76.1M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Pretax Margin	3.41%
Profit Margin	-2.28%
Profit Per Employee	$-4,756
ROA	3.71
Roa5y	3.71
ROCE	6.35
ROE	2.75
Roe5y	2.78
ROIC	5.51
Roic5y	4.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.37%
Cagr1y	-37.67%
Cagr3y	-25.7%
Cagr5y	-22.49%
EPS Growth Quarters	4
EPS Growth Years	1
FCF Growth	20.02%
FCF Growth3 Y	46.03%
FCF Growth5 Y	-1.32%
OCF Growth	5.5%
OCF Growth Q	95%
OCF Growth10 Y	10.82%
OCF Growth3 Y	22.18%
OCF Growth5 Y	0.89%
Revenue Growth	5.38x
Revenue Growth Q	4.5x
Revenue Growth Quarters	23x
Revenue Growth Years	12x
Revenue Growth3 Y	8.62x
Revenue Growth5 Y	11.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.42
Assets	$8B
Cash	$182.3M
Current Assets	$1.1B
Current Liabilities	$581.7M
Debt	$4B
Debt EBITDA	$5.43
Debt Equity	$1.16
Debt FCF	$19.42
Equity	$3.5B
Interest Coverage	1.7
Liabilities	$4.6B
Long Term Assets	$7B
Long Term Liabilities	$4B
Net Cash	$-3.9B
Net Cash By Market Cap	$-206
Net Debt EBITDA	$5.91
Net Debt Equity	$1.11
Net Debt FCF	$18.54
Tangible Book Value	$-3.6B
Tangible Book Value Per Share	$-27.45
WACC	8.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.86
Inventory Turnover	27.36
Net Working Capital	$461.1M
Quick ratio	1.35
Working Capital	$500.8M
Working Capital Turnover	$6.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.09%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	3.81%
1Y total return	-37.65%
200-day SMA	17.47
3Y total return	-58.99%
50-day SMA	13.32
50-day SMA vs 200-day SMA	50under200
5Y total return	-72.02%
All Time High	69.58
All Time High Change	-79.25%
All Time High Date	2021-06-25
All Time Low	4
All Time Low Change	261%
All Time Low Date	2020-03-18
ATR	0.64
Beta	1.99
Beta1y	2.01
Beta2y	1.24
Ch YTD	-6.54
High	14.54
High52	24.18
High52 Date	2025-05-16
High52ch	-40.28%
Low	14.14
Low52	11.41
Low52 Date	2026-03-30
Low52ch	26.56%
Ma50ch	8.41%
Price vs 200-day SMA	-17.33%
RSI	59.51
RSI Monthly	37.49
RSI Weekly	44.76
Sharpe ratio	-0.86x
Sortino ratio	-0.92
Total Return	-1.09%
Tr YTD	-6.54
Tr1m	14.24%
Tr1w	1.19%
Tr3m	6.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	3
Analyst Price Target Top	$22.67
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.14
Earnings Revenue Estimate	798,097,744x
Earnings Revenue Estimate Growth	2.85x
Operating Income	$474M
Operating Income Growth	0.11
Operating Income Growth Q	-6.14
Operating Income Growth3 Y	8.29
Operating Income Growth5 Y	17.81
Operating margin	14.18
Price target	$22.25
Price Target Change	$54.09
Price Target Change Top	$56.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56,905,941%
Float Percent	43.92%
Net Borrowing	70,100,000
Shares Insiders	1.93%
Shares Institutions	63.53%
Shares Out	129,579,914
Shares Qo Q	0.26%
Shares Yo Y	1.09%
Short Float	27.83%
Short Ratio	13.39
Short Shares	12.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$195M
Average Volume	1,393,297.95x
Bv Per Share	13.03
CAPEX	$-72M
Ch10y	3.81
Ch1m	14.24
Ch1w	1.19
Ch1y	-37.65
Ch3m	6.49
Ch3y	-58.99
Ch5y	-72.02
Ch6m	-32.84
Change	0.91%
Change From Open	0.91
Close	14.31
Days Gap	0
Depreciation Amortization	178,200,000
Dollar Volume	18,229,518.1
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$474M
EBITDA	$652.2M
EPS	$-0.6
F Score	3
FCF	$208M
FCF EV Yield	3.63x
FCF Per Share	$1.61
Financing CF	-143,400,000
Fiscal Year End	December
Founded	2,004
Goodwill	5,205,200,000
Income Tax	$16.8M
Investing CF	-183,600,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	15.86
Ma150ch	-8.98%
Ma20	14.12
Ma20ch	2.3%
Net CF	-47,000,000
Next Earnings Date	2026-08-04
Open	14.31
Optionable	Yes
P FCF Ratio	9
P OCF Ratio	6.68
Position In Range	75
Post Close	14.44
Postmarket Change Percent	2.15
Postmarket Price	$14.75
Ppne	1,416,400,000
Price Date	2026-05-08
Price EBITDA	$2.87
Relative Volume	0.92x
Revenue	3,343,600,000x
SBC By Revenue	0.39x
Share Based Comp	13,000,000
Tax By Revenue	0.5x
Tax Rate	14.75%
Tr6m	-32.84%
Us State	Tennessee
Volume	1,262,432
Z Score	0.86

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SGRY pay a dividend?

Capital-return profile for this ticker.

Performance

SGRY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SGRY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+63.5%

Float: +43.9% of shares outstanding

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SGRY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.5

Neutral momentum band

Price vs 200-day MA

-17.3%

50/200-day relationship not available

Beta (5Y)

1.99

More volatile than the market

Sharpe ratio

-0.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SGRY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SGRY stock rating?

Surgery Partners, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SGRY analysis?

The full report lives at /stocks/SGRY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SGRY?

The latest report frames SGRY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SGRY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.